Remove 2006 Remove Bipolar disorder Remove Manufacturing
article thumbnail

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

Mad in America

This turn to ketamine is occurring despite the fact that the Food and Drug Administration has repeatedly warned that the FDA has not approved ketamine for the treatment of any psychiatric disorder (though controversially approving esketamine nasal spray). appeared first on Mad In America.

article thumbnail

Medication Overload, Part II: The Explosion of Drugs for Kids

Mad in America

Bristol Myers, along with the many other manufacturing plants located in the surrounding area, helped to grow and strengthen our local economy. By the mid-2000s, because of cheaper costs to manufacture penicillin in foreign countries, the plant downsized considerably. She was four years old.